|
|
||||||||
|
FIGURE 5. Outcome vs. curve type and early FMISO uptake: All patients with type 1 were responders. Patients with type 2 or 3 could further be discriminated by analyzing SUV 02 min after injection (A) and 514 min after injection (B). Area enclosed by rectangle represents area of high risk: All patients with data within this range experienced relapse.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |